N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide

C32H25N5O3S — CID 17337285

IUPACN-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide
SMILESCc1ccc(NCc2nnc(SCC(=O)Nc3cccc4c3C(=O)c3ccccc3C4=O)n2-c2ccccc2)cc1
InChIInChI=1S/C32H25N5O3S/c1-20-14-16-21(17-15-20)33-18-27-35-36-32(37(27)22-8-3-2-4-9-22)41-19-28(38)34-26-13-7-12-25-29(26)31(40)24-11-6-5-10-23(24)30(25)39/h2-17,33H,18-19H2,1H3,(H,34,38)
InChIKeyKDLVPYIGJPRAMN-UHFFFAOYSA-N
MW559.65 g/mol
LogP5.69
Rot. Bonds8

About N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide

N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide (PubChem CID 17337285) has the molecular formula C32H25N5O3S and a molecular weight of 559.65 g/mol. Its IUPAC name is N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide.

Molecular Properties

Compound NameN-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide
PubChem CID17337285
Molecular FormulaC32H25N5O3S
Molecular Weight559.65 g/mol
Exact Mass559.17
IUPAC NameN-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide
SMILESCc1ccc(NCc2nnc(SCC(=O)Nc3cccc4c3C(=O)c3ccccc3C4=O)n2-c2ccccc2)cc1
InChIInChI=1S/C32H25N5O3S/c1-20-14-16-21(17-15-20)33-18-27-35-36-32(37(27)22-8-3-2-4-9-22)41-19-28(38)34-26-13-7-12-25-29(26)31(40)24-11-6-5-10-23(24)30(25)39/h2-17,33H,18-19H2,1H3,(H,34,38)
InChIKeyKDLVPYIGJPRAMN-UHFFFAOYSA-N
XLogP5.69
TPSA105.98 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500559.65
LogP ≤ 55.69
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quinone_A(370)', 'substructure': 'N/A'}

Analyze N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide?
The IUPAC name of N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide (CID 17337285) is N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide.
What is the SMILES notation for N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide?
The canonical SMILES for N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide is Cc1ccc(NCc2nnc(SCC(=O)Nc3cccc4c3C(=O)c3ccccc3C4=O)n2-c2ccccc2)cc1.
What is the InChIKey of N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide?
The InChIKey is KDLVPYIGJPRAMN-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H25N5O3S/c1-20-14-16-21(17-15-20)33-18-27-35-36-32(37(27)22-8-3-2-4-9-22)41-19-28(38)34-26-13-7-12-25-29(26)31(40)24-11-6-5-10-23(24)30(25)39/h2-17,33H,18-19H2,1H3,(H,34,38).
What are the key properties of N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide?
N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide has a molecular weight of 559.65 g/mol, XLogP of 5.69, 8 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-(9,10-dioxoanthracen-1-yl)-2-[[5-[(4-methylanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide is sourced from PubChem (CID 17337285), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).